oxybutynin/atomoxetine (AD036) / Apnimed - LARVOL DELTA

Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing (clinicaltrials.gov) - P2 | N=53 | Completed | Sponsor: Brigham and Women's Hospital | Recruiting ➔ Completed

Trial completion • CNS Disorders • Sleep Disorder

Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing (clinicaltrials.gov) - P2; N=56; Recruiting; Sponsor: Brigham and Women's Hospital; Not yet recruiting ➔ Recruiting

Enrollment open • CNS Disorders • Sleep Disorder

Crossover Trial of AD036 in Obstructive Sleep Apnea (clinicaltrials.gov) - P2; N=62; Completed; Sponsor: Apnimed; Active, not recruiting ➔ Completed

Trial completion • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder